InvestSMART

Island Pharmaceuticals Limited (ASX: ILA) - Announcements

Current share price for ILA : $0.335 0.045 (11.84%)+

ASX company news and announcements for Island Pharmaceuticals Limited (ILA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Island Pharmaceuticals Limited (ILA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Island Pharmaceuticals Limited (ILA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Island Pharmaceuticals Limited (ILA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$99 FDA Grants Orphan Designation for Galidesivir in Marburg 17 Jun 2026 8:54AM $0.355 $0.335 fallen by 5.63%
$99 Investor Presentation - Asia Dengue Summit 16 Jun 2026 9:58AM $0.365 $0.335 fallen by 8.22%
$99 Investor presentation (updated) 11 Jun 2026 12:25PM $0.365 $0.335 fallen by 8.22%
$99 Investor presentation 11 Jun 2026 9:46AM $0.365 $0.335 fallen by 8.22%
$99 Island Secures USAMRIID Support for Galidesivir Study 10 Jun 2026 8:53AM $0.350 $0.335 fallen by 4.29%
$99 Island Advances Galidesivir GMP Manufacturing for Biodefence 4 Jun 2026 9:03AM $0.370 $0.335 fallen by 9.46%
$99 Island Adds Biodefence Leader as Filovirus Risks Escalate 21 May 2026 9:25AM $0.400 $0.335 fallen by 16.25%
$99 Island Bolsters US Biodefence Readiness Ahead of Trials 19 May 2026 8:44AM $0.425 $0.335 fallen by 21.18%
$99 Cleansing Notice 28 Apr 2026 8:30AM $0.380 $0.335 fallen by 11.84%
$99 Application for quotation of securities - ILA 28 Apr 2026 8:23AM $0.380 $0.335 fallen by 11.84%
$99 Quarterly Appendix 4C and Activities Report 27 Apr 2026 9:46AM $0.375 $0.335 fallen by 10.67%
$99 Cleansing Notice 30 Mar 2026 11:19AM $0.370 $0.335 fallen by 9.46%
$99 Application for quotation of securities - ILA 30 Mar 2026 11:17AM $0.370 $0.335 fallen by 9.46%
$99 Cleansing Notice 23 Mar 2026 10:29AM $0.380 $0.335 fallen by 11.84%
$99 Application for quotation of securities - ILA 23 Mar 2026 10:27AM $0.380 $0.335 fallen by 11.84%
$99 Antiviral pipeline expansion through strategic collaboration 9 Mar 2026 9:47AM $0.420 $0.335 fallen by 20.24%
$99 US Government collaboration for Galidesivir development 4 Mar 2026 9:22AM $0.370 $0.335 fallen by 9.46%
$99 Trading Halt 2 Mar 2026 9:37AM $0.370 $0.335 fallen by 9.46%
$99 Appendix 4D & Half-Year Financial Statements 25 Feb 2026 4:21PM $0.360 $0.335 fallen by 6.94%
$99 Cleansing Notice 16 Feb 2026 8:28AM $0.385 $0.335 fallen by 12.99%
$99 Application for quotation of securities - ILA 16 Feb 2026 8:21AM $0.385 $0.335 fallen by 12.99%
$99 Response to ASX Query Letter 10 Feb 2026 10:45AM $0.420 $0.335 fallen by 20.24%
$99 Investor presentation 5 Feb 2026 9:57AM $0.420 $0.335 fallen by 20.24%
$99 Proposed issue of securities - ILA 4 Feb 2026 9:34AM $0.390 $0.335 fallen by 14.10%
$99 $9m placement to advance US biodefence opportunity 4 Feb 2026 9:34AM $0.390 $0.335 fallen by 14.10%

26 - 50 of 455 results

Page 2 of 19

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.